-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vor Biopharma Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
- Vor Biopharma Inc. Depreciation for the quarter ending September 30, 2024 was $900K, unchanged year-over-year.
- Vor Biopharma Inc. Depreciation for the twelve months ending September 30, 2024 was $3.6M, a 11.2% increase year-over-year.
- Vor Biopharma Inc. annual Depreciation for 2023 was $3.49M, a 38.3% increase from 2022.
- Vor Biopharma Inc. annual Depreciation for 2022 was $2.53M, a 76.1% increase from 2021.
- Vor Biopharma Inc. annual Depreciation for 2021 was $1.43M, a 137% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)